Athletes Who Test Positive on Multiple Domains of the Vestibular-Ocular Motor Screen Take Longer to Return to Play

在多个前庭眼动筛查项目中检测呈阳性的运动员需要更长时间才能重返赛场。

阅读:1

Abstract

BACKGROUND: The Vestibular-Ocular Motor Screen (VOMS) is a validated tool that is used to assess symptom provocation with vestibular and ocular testing following sport-related concussion (SRC). It is unknown if the involvement of multiple domains on the VOMS effects time to return to play (RTP) following SRC. HYPOTHESIS: Athletes who tested positive on >3 domains of the VOMS would take longer to RTP than athletes who tested positive on ≤3 domains of the VOMS. STUDY DESIGN: Retrospective cohort study. LEVEL OF EVIDENCE: Level 3. METHODS: A total of 928 athletes were enrolled from a concussion clinic. The median VOMS score was used to divide these athletes into 2 groups, those who tested positive on ≤3 domains (LOW) and those who tested positive on >3 domains (HIGH). Independent t-tests were used to assess for differences in time to RTP between groups. A simple linear regression was carried out to assess the influence of positive testing on the VOMS domains at the time of first evaluation on time to RTP. RESULTS: Independent t-tests demonstrated a significant difference in time to RTP between the LOW and HIGH groups, with the LOW group returning to play an average of 12.81 days sooner than the HIGH group. The simple linear regression showed that approximately 10.8% of the time to RTP after SRC could be explained by the number of domains that test positive at initial evaluation. CONCLUSION: Athletes who test positive on >3 domains of the VOMS take longer to RTP than athletes who test positive on ≤3 domains of the VOMS at the time of initial evaluation. CLINICAL RELEVANCE: The VOMS may be utilized to help determine which athletes may take longer to RTP based on the number of domains that are affected after SRC.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。